# FDA 483 - Marc A. Bjurlin, D.O. - July 22, 2024

Source: https://www.globalkeysolutions.net/records/483/marc-a-bjurlin-do/54feb691-d459-4437-aab3-854092ba5b77

> FDA 483 for Marc A. Bjurlin, D.O. on July 22, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Marc A. Bjurlin, D.O.
- Inspection Date: 2024-07-22
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: The FDA inspected Marc A. Bjurlin, D.O. at UNC Hospitals Urology Clinic in Chapel Hill, NC, regarding a clinical investigation. The inspection revealed that the study was not conducted according to the investigational plan, specifically failing to perform protocol-required assessments for enrolled subjects. This indicates a significant deviation from the approved study protocol.

## Related Officers

- [Leon L. Crawley](https://www.globalkeysolutions.net/people/leon-l-crawley/973f0ced-69a4-4adb-9e3c-e088e78a4516)

Company: https://www.globalkeysolutions.net/companies/marc-a-bjurlin-do/58486758-5844-466a-bd48-dcbf4a20ef7b

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7